pI: 7.2281 |
Length (AA): 479 |
MW (Da): 54165 |
Paralog Number:
0
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
24 | 476 | 1t2b (A) | 11 | 400 | 15.00 | 0 | 1 | 0.99 | -0.42 |
29 | 475 | 1z10 (A) | 30 | 494 | 18.00 | 0 | 1 | 1.24 | -1.43 |
32 | 476 | 1x8v (A) | 6 | 449 | 30.00 | 0 | 1 | 1.32 | -0.89 |
29 | 476 | 4c27 (A) | 29 | 477 | 77.00 | 0 | 1 | 1.91568 | -1.39 |
30 | 476 | 3l4d (A) | 30 | 476 | 97.00 | 0 | 1 | 2.13639 | -1.4 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | amastigotes. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_129288)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G11680 | sterol 14-demethylase |
Candida albicans | CaO19.8538 | cytochrome P450 lanosterol 14-alpha -demethylase |
Candida albicans | CaO19.922 | cytochrome P450 lanosterol 14-alpha -demethylase |
Dictyostelium discoideum | DDB_G0279403 | cytochrome P450 family protein |
Homo sapiens | ENSG00000001630 | cytochrome P450, family 51, subfamily A, polypeptide 1 |
Leishmania braziliensis | LbrM.11.0880 | lanosterol 14-alpha-demethylase, putative |
Leishmania donovani | LdBPK_111100.1 | Lanosterol 14-alpha demethylase |
Leishmania infantum | LinJ.11.1100 | lanosterol 14-alpha-demethylase, putative |
Leishmania major | LmjF.11.1100 | lanosterol 14-alpha-demethylase, putative |
Leishmania mexicana | LmxM.11.1100 | lanosterol 14-alpha-demethylase, putative |
Mus musculus | ENSMUSG00000001467 | cytochrome P450, family 51 |
Mycobacterium tuberculosis | Rv0764c | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) |
Mycobacterium ulcerans | MUL_0473 | cytochrome P450 51B1 Cyp51B1 |
Oryza sativa | 4350614 | Os11g0525200 |
Oryza sativa | 4338097 | Os05g0211100 |
Saccharomyces cerevisiae | YHR007C | sterol 14-demethylase |
Trypanosoma brucei gambiense | Tbg972.11.7000 | lanosterol 14-alpha-demethylase,cytochrome P450 51A1, putative |
Trypanosoma brucei | Tb927.11.6210 | Lanosterol 14-alpha demethylase |
Trypanosoma congolense | TcIL3000.11.6740 | Lanosterol 14-alpha demethylase |
Trypanosoma cruzi | TcCLB.510101.50 | Lanosterol 14-alpha demethylase |
Trypanosoma cruzi | TcCLB.506297.260 | Lanosterol 14-alpha demethylase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu779 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.02.4080 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.4080 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.4080 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.4080 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
YHR007C | Saccharomyces cerevisiae | inviable | yeastgenome |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania mexicana | 6333 55811 68461 |
Annotator: | aaronjr@u.washington.edu. | Comment: | chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in cell assay; inhibitor D0870. | References: | 9124841 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania braziliensis | 6333 55811 68461 |
Annotator: | aaronjr@u.washington.edu. | Comment: | chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in cell assay; inhibitor D0870. | References: | 9124841 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania mexicana | 27007 55811 |
Annotator: | aaronjr@u.washington.edu. | Comment: | chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in cell assay; . | References: | 12739804 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 27007 55811 |
Annotator: | aaronjr@u.washington.edu. | Comment: | chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in cell assay; . | References: | 12739804 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania major | 27007 55811 |
Annotator: | aaronjr@u.washington.edu. | Comment: | chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in cell assay; . | References: | 12739804 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania mexicana | 6333 68461 |
Annotator: | aaronjr@u.washington.edu. | Comment: | Drug: (sodium stibogluconate) 16037-91-5. chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (human); Q2HWD2_LEIAM; . | References: | 1311351 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | host (GO:0018995) | Leishmania braziliensis | 6333 68461 |
Annotator: | aaronjr@u.washington.edu. | Comment: | Drug: (sodium stibogluconate) 16037-91-5. chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (human); Q2HWD2_LEIAM; . | References: | 1311351 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | host (GO:0018995) | Leishmania mexicana | 6333 68461 |
Annotator: | aaronjr@u.washington.edu. | Comment: | Drug: (sodium stibogluconate) 16037-91-5. chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (human); Q2HWD2_LEIAM; . | References: | 1311351 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania braziliensis | 6333 68461 |
Annotator: | aaronjr@u.washington.edu. | Comment: | Drug: (sodium stibogluconate) 16037-91-5. chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (human); Q2HWD2_LEIAM; . | References: | 1311351 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | No drug identifiers listed for this gene. |
Annotator: | aaronjr@u.washington.edu. | Comment: | Drug: (SCH 56592 posaconazole) 171228-49-2. chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (balb/c mouse); Q2HWD2_LEIAM; . | References: | 10582881 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | host (GO:0018995) | Leishmania donovani | No drug identifiers listed for this gene. |
Annotator: | aaronjr@u.washington.edu. | Comment: | Drug: (SCH 56592 posaconazole) 171228-49-2. chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (balb/c mouse); Q2HWD2_LEIAM; . | References: | 10582881 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | host (GO:0018995) | Leishmania amazonensis | No drug identifiers listed for this gene. |
Annotator: | aaronjr@u.washington.edu. | Comment: | Drug: (SCH 56592 posaconazole) 171228-49-2. chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (balb/c mouse); Q2HWD2_LEIAM; . | References: | 10582881 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | No drug identifiers listed for this gene. |
Annotator: | aaronjr@u.washington.edu. | Comment: | Drug: (SCH 56592 posaconazole) 171228-49-2. chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (balb/c mouse); Q2HWD2_LEIAM; . | References: | 10582881 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | host (GO:0018995) | Leishmania major | 27007 |
Annotator: | aaronjr@u.washington.edu. | Comment: | chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (human); Q2HWD2_LEIAM; . | References: | 16445420 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania major | 27007 |
Annotator: | aaronjr@u.washington.edu. | Comment: | chemical inhibition with sterol 14-α-demethylase (1.14.13.70) inhibitors leads to slow growth of Leishmania sp. in vivo (human); Q2HWD2_LEIAM; . | References: | 16445420 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.8
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References |
5 literature references were collected for this gene.